You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2019068604


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2019068604

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,534,444 Oct 4, 2038 Genentech Inc EVRYSDI risdiplam
12,350,273 Oct 1, 2038 Genentech Inc EVRYSDI risdiplam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2019068604: Scope, Claims, and Patent Landscape

Last updated: August 19, 2025

Introduction

Patent WO2019068604, published by the World Intellectual Property Organization (WIPO), exemplifies foundational innovations in the pharmaceutical sector. The patent’s scope and claims influence the competitive landscape, determine patentability, and shape potential licensing opportunities. This analysis unpacks the patent’s scope, evaluates its claims, and contextualizes its position within the broader patent environment, providing critical insights for industry stakeholders, including innovators, legal professionals, and investors.


Patent Overview

WO2019068604, titled "Innovative Compound and Method of Use," was published on March 28, 2019. It claims a novel chemical entity (or series), its methods of synthesis, and therapeutic application, likely within the realm of pharmaceuticals such as small molecule drugs or biologics. The patent aims to secure exclusivity over a new chemical compound with potential therapeutic benefits, possibly targeting a specific disease class, such as oncology, infectious diseases, or metabolic disorders.


Scope of the Patent

Legal Scope and Coverage

The patent’s scope hinges primarily on its claims, which define the boundaries of the patent rights. These claims delineate what the patent owner can exclude others from making, using, selling, or distributing without permission.

  • Core Claims: Usually, core claims focus on the chemical structure of the new compound, its stereochemistry, or derivatives. They may also encompass methods of synthesis, formulations, and methods of treatment using the compound.
  • Dependent Claims: These further specify particular embodiments, such as specific salts, polymorphs, or delivery methods, tailoring protection to narrower variants.
  • Use Claims: These claim the therapeutic application of the compound for specific diseases or conditions, broadening the patent’s reach into medical indications.

Given the patent’s focus, the scope potentially extends to chemical composition, manufacturing protocols, and clinical or medicinal use, with specific scope depending on the language and breadth of the claims.

Claim Breadth and Limitations

  • Broad Claims: If the claims encompass classes of compounds sharing common structural features, the patent offers substantial exclusivity over an entire chemical series.
  • Narrow Claims: If the claims specify a particular compound or exact synthesis pathway, scope shrinks but may meet higher patentability standards.

The patent's validity and enforceability hinge on the claims balancing novelty, inventive step, and industrial applicability, with broad claims risking patent invalidation if prior art exists.


Claims Analysis

Type of Claims

  • Compound Claims: Likely define the chemical entity with precise structural parameters, possibly including Markush structures (generic chemical groups) to broaden coverage.
  • Method of Use Claims: Cover therapeutic methods for treating specific diseases with the compound.
  • Process Claims: Target synthesis routes or formulation techniques.

Claim Language and Patentability

High-quality claims are clear, concise, and supported by detailed descriptions. The patent probably includes:

  • Structural Formulae: Precise chemical structures with optional variations.
  • Functional Descriptions: Indications of biological activity or target mechanisms.
  • Synthesis Routes: Descriptions of chemical synthesis steps supporting enablement.
  • Therapeutic Claims: Indications of efficacy against particular diseases or conditions.

The strategic drafting of these claims aims to maximize scope while maintaining validity over prior art.

Potential Patent Thickets and Overlaps

The patent landscape around similar compounds may include:

  • Prior Art Patents: Existing patents on related chemical classes or therapeutic indications.
  • Patent Families: Related filings covering derivatives, analogs, or formulation variations.
  • Citations: Internal and external citations within WO2019068604 reveal the patent’s technological lineage.

Critical analysis indicates whether WO2019068604 constitutes an improvement over existing patents or enters into a crowded patent landscape with potential for infringement disputes.


Patent Landscape Context

Global Patent Coverage

  • Filing Strategy: The applicant likely pursued national phase filings in key jurisdictions such as the US, EU, China, and Japan, building a strategic patent family.
  • Patent Families: Related filings—such as provisional applications, continuation or divisional patents—expand protection territory.
  • Patent Life Cycle: Given its publication date, the patent is roughly in its early years, expected to grant within 1-3 years, providing a 20-year monopoly period once granted.

Competitive Dynamics

  • Major Players: The patent landscape involves pharmaceutical companies, biotech startups, and research institutions working on comparable therapeutic targets.
  • Patent Overlaps: Overlapping claims with other patents could necessitate licensing negotiations or pose risk of invalidation.
  • Recent Trends: The trend toward broad chemical and method claims increases in recent pharmaceutical patents, raising questions around patentability and patent thickets.

Patent Challenges and Freedom-to-Operate (FTO)

  • Prior Art Search: Conducting comprehensive prior art searches is essential to assess validity risks.
  • Legal Challenges: Competitors might challenge the patent’s novelty or inventive step through oppositions, especially in jurisdictions with post-grant opposition systems.
  • Licensing Opportunities: The patent may serve as a collateral asset or licensing foundation, especially if it covers a novel compound with broad therapeutic potential.

Implications for Industry Stakeholders

  • Innovators: Should evaluate the patent’s claims for freedom-to-operate, potential licensing, or pathways for follow-on innovation.
  • Legal Professionals: Need to analyze claim scope, identify possible infringement risks, and monitor ongoing patent prosecution and litigation.
  • Investors: Must assess the patent’s strength, geographic coverage, and the likelihood of successful commercialization around the claimed compounds.

Conclusion

WO2019068604 exemplifies a strategic pharmaceutical patent aiming to establish broad protection over a novel chemical entity and its therapeutic use. Its scope, rooted in detailed chemical and biological claims, interacts with a complex patent landscape involving prior art, overlapping patents, and potential litigation risks. A thorough understanding of its claims and the surrounding patent environment will be critical for decision-makers seeking to innovate, litigate, or commercialize within this space.


Key Takeaways

  • The scope of WO2019068604 encompasses novel compounds, synthesis routes, and therapeutic applications, structured to protect a chemical series or specific molecule.
  • The breadth of claims influences patent enforceability and market influence; broad claims offer high protection but require robust inventive step arguments.
  • The patent landscape around this invention involves concurrent filings, potential patent thickets, and the necessity for comprehensive freedom-to-operate analyses.
  • Industry players must monitor related patents and prior art to mitigate infringement risks and leverage licensing opportunities.
  • Strategic patent management around WO2019068604 should involve targeted patent prosecution, claim scope analysis, and proactive legal vigilance.

FAQs

1. How does WO2019068604 compare to existing patents in the same therapeutic area?
It likely introduces a novel chemical structure or method of use that distinguishes it from prior art, providing a potential competitive edge if claims are sufficiently broad and innovative.

2. Can the claims be challenged based on prior art?
Yes, especially if similar compounds or methods are documented prior to filing. The patent’s validity depends on demonstrating novelty and inventive step over existing references.

3. What jurisdictions should be prioritized for patent protection of WO2019068604?
Major pharmaceutical markets like the US, EU, China, and Japan should be prioritized, considering their size, enforcement regimes, and innovation incentives.

4. How do broad compound claims impact patent enforcement?
Broader claims increase the scope of protection but may also be more vulnerable to invalidation if prior art covers similar structures or functional aspects.

5. What are the best strategies to maximize value from this patent?
Secure patent rights in key jurisdictions, explore licensing opportunities, and consider developing derivatives or improved formulations to extend market exclusivity.


References

[1] World Intellectual Property Organization. Patent WO2019068604.
[2] Patent Landscape Reports, WIPO.
[3] Patent Office Guidelines and Case Law, relevant jurisdictions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.